{"entity":{"id":"nct00943449","kind":"trial","name":"4SC-201 (Resminostat) and Sorafenib in Advanced Hepatocellular Carcinoma","aka":[],"tldr":"A phase 2 trial of Resminostat and Sorafenib in Hepatocellular carcinoma, run by 4SC AG, completed.","summary":"4SC-201 (Resminostat) and Sorafenib in Advanced Hepatocellular Carcinoma is a phase 2 interventional study registered as NCT00943449 by 4SC AG, with 57 participants recorded, started 2009-07 and reaching its primary completion in 2012-06. Interventions recorded: 4SC-201, Sorafenib. Conditions recorded: Hepatocellular Carcinoma.\n\nLinked to the drug Resminostat because the registry names it among its interventions and Hepatocellular carcinoma among its conditions. Registry record only: no result has been read by an editor.","status":"completed","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT00943449","url":"https://clinicaltrials.gov/study/NCT00943449"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["hcc"],"sections":[],"technologies":[],"targets":[],"drugs":["resminostat","sorafenib"],"companies":["4sc"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT00943449","phase":"2","setting":"A Proof-of-concept Phase II Study to Evaluate Efficacy, Safety and Pharmacokinetics of 4SC-201 and the Treatment Combination of Sorafenib Plus 4SC-201 in Patients With Hepatocellular Carcinoma Exhibiting Progressive Disease Under Sorafenib Treatment","sponsor":"4SC AG","enrolled":57,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct00943449/","neighbours":{"cancer":[{"id":"hcc","kind":"cancer","name":"Hepatocellular carcinoma","route":"/cancers/hcc/"}],"drug":[{"id":"resminostat","kind":"drug","name":"Resminostat","route":"/drugs/resminostat/"},{"id":"sorafenib","kind":"drug","name":"Sorafenib","route":"/drugs/sorafenib/"}],"company":[{"id":"4sc","kind":"company","name":"4SC","route":"/companies/4sc/"}]}}